Moscovici A, Bernheim J, Popovtzer M M, Rubinger D
Nephrology and Hypertension Service, Hadassah University Hospital, Jerusalem, Israel.
Nephrol Dial Transplant. 1996;11 Suppl 3:146-52. doi: 10.1093/ndt/11.supp3.146.
The rat remnant kidney, a popular model of experimental renal failure, has also been used to assess the histological bone changes associated with reduction in renal mass. The suitability of this model has been challenged, especially with regard to the standardization of animals from different age groups and various degrees of renal failure. The present study was undertaken: (1) to better evaluate the histomorphometric changes associated with reduction in renal mass; (2) to assess these changes over a longer follow-up period as compared to those of matched intact animals; (3) to define the response to pharmacological doses of calcitriol. Male rats were evaluated 4 and 8 weeks after induction of renal failure (5/6 nephrectomy) and compared with age-matched control rats with intact kidneys. Plasma biochemistry, creatinine clearance and parathyroid hormone (PTH) were obtained from normal rats and from the rats with chronic renal insufficiency. Histomorphometric studies were performed in all animals on the right tibial bone. Induction of renal failure of 4 weeks' duration (short-term study, age 16 weeks) was associated with increased PTH and bone resorption, but suppressed bone formation. At long-term follow-up (rats aged 20 weeks), the suppression in bone formation was even more prominent. These changes were assessed considering normal bone histomorphometry during the process of growing. Calcitriol administration was associated with a significant suppression of bone resorption and a spectacular increase in all osteoid parameters. The bone formation rate, however, remained in the same low range as that in untreated animals. This model of renal osteodystrophy is similar to human secondary hyperparathyroidism with regard to the enhanced bone resorption, but differs by the marked decrease in bone formation. There was a remarkable similarity between the response of rats with renal failure and that of patients with severe secondary hyperparathyroidism to large doses of calcitriol, leading in both to adynamic bone disease. Keeping in mind the species differences, the bone changes developing in the uraemic rats may be useful in understanding certain aspects of human renal osteodystrophy.
大鼠残肾是一种常用的实验性肾衰竭模型,也被用于评估与肾质量减少相关的组织学骨变化。该模型的适用性受到了质疑,尤其是在不同年龄组和不同程度肾衰竭动物的标准化方面。本研究旨在:(1)更好地评估与肾质量减少相关的组织形态计量学变化;(2)与匹配的完整动物相比,在更长的随访期内评估这些变化;(3)确定对药理剂量骨化三醇的反应。雄性大鼠在诱导肾衰竭(5/6肾切除术)后4周和8周进行评估,并与年龄匹配的完整肾脏对照大鼠进行比较。从正常大鼠和慢性肾功能不全大鼠中获取血浆生化指标、肌酐清除率和甲状旁腺激素(PTH)。对所有动物的右胫骨进行组织形态计量学研究。持续4周的肾衰竭诱导(短期研究,16周龄)与PTH升高和骨吸收增加有关,但骨形成受到抑制。在长期随访中(20周龄大鼠),骨形成的抑制更为明显。在生长过程中考虑正常骨组织形态计量学来评估这些变化。给予骨化三醇与骨吸收的显著抑制和所有类骨质参数的显著增加有关。然而,骨形成率仍处于与未治疗动物相同的低水平。这种肾性骨营养不良模型在骨吸收增强方面与人类继发性甲状旁腺功能亢进相似,但在骨形成明显减少方面有所不同。肾衰竭大鼠与严重继发性甲状旁腺功能亢进患者对大剂量骨化三醇的反应有显著相似性,两者都会导致动力缺失性骨病。考虑到物种差异,尿毒症大鼠中发生的骨变化可能有助于理解人类肾性骨营养不良的某些方面。